SCHEMBL23930432

SCHEMBL23930432

CC(CI)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28945838 1.00
SCHEMBL258152 0.82 SLC22A6 (0.50)
SCHEMBL96227 0.80
SCHEMBL14109598 0.79 SLC22A6 (0.47)
SCHEMBL10902055 0.79 SLC22A6 (0.47)
SCHEMBL11112780 0.79 SLC22A6 (0.47)
SCHEMBL11112412 0.79 SLC22A6 (0.47)
Ethane SCHEMBL5968227 0.79 SLC22A6 (0.47)
Ammonia Solution, Strong SCHEMBL28582304 0.79 TDP1 (0.53)
SCHEMBL6738239 0.79 SLC22A6 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4139294-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4x Discovery Limited (GB) 2023-03-01 EP disclosed
CN-115667243-A Tetrahydroisoquinoline compounds as NRF2 activators 希四克斯探索有限公司 2023-01-31 CN disclosed
WO-2021214470-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4X DISCOVERY LIMITED (GB) 2021-10-28 WO disclosed